This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on August 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Notice of Intent to Sole Source – Roche Diagnostics Corporation
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health Clinical Center intends to award a one-year, firm-fixed-price contract to Roche Diagnostics Corporation for an automated molecular diagnostic testing platform via a reagent rental arrangement. Running from August 18, 2026, to August 17, 2027, with an estimated value of $350,000, the procurement focuses on implementing the Roche cobas 5800 system. This platform will centralize testing for CMV, EBV, BKV, and various respiratory viruses, replacing fragmented systems to reduce manual handling, minimize transcription errors, and transition from laboratory-developed tests to FDA-cleared assays. The scope includes the provision of instrumentation, reagents, controls, calibrators, consumables, technical support, operator training, and warranty coverage. This acquisition is being conducted as a sole-source procurement under FAR Part 13 Simplified Acquisition Procedures, specifically subpart 13.106-1(b)(1), as Roche is determined to be the only reasonably available source capable of meeting the laboratory's requirements for instrument redundancy, footprint efficiency, and operational continuity. The place of performance is the NIH Clinical Center in Bethesda, Maryland. This notice serves as an intent to sole source rather than a request for quotations; interested parties may submit comments to Contract Specialist Ryssa Nix by August 16, 2026.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
This procurement is for a one-year (08/18/2026 – 08/17/2027) contract for automated molecular diagnostic testing platform through a reagent rental arrangement with Roche Diagnostics Corporation to support clinical molecular diagnostic testing performed for patients of the NIH Clinical Center.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
Notice Type: Notice of Intent
NAICS Code: 541690
PSC Code: 6550
Posted Date: 08/11/2026
Close Date: 08/16/2026 12pm EST
End User IC: Clinical Center
POC Name: Ryssa Nix
Email Address: Ryssa.nix@nih.gov
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
